Literature DB >> 19470517

Pregnancy modifies the large conductance Ca2+-activated K+ channel and cGMP-dependent signaling pathway in uterine vascular smooth muscle.

Charles R Rosenfeld1, Xiao-tie Liu, Kevin DeSpain.   

Abstract

Regulation of uteroplacental blood flow (UPBF) during pregnancy remains unclear. Large conductance, Ca(2+)-activated K(+) channels (BK(Ca)), consisting of alpha- and regulatory beta-subunits, are expressed in uterine vascular smooth muscle (UVSM) and contribute to the maintenance of UPBF in the last third of ovine pregnancy, but their expression pattern and activation pathways are unclear. We examined BK(Ca) subunit expression, the cGMP-dependent signaling pathway, and the functional role of BK(Ca) in uterine arteries (UA) from nonpregnant (n = 7), pregnant (n = 38; 56-145 days gestation; term, approximately 150 days), and postpartum (n = 15; 2-56 days) sheep. The alpha-subunit protein switched from 83-87 and 105 kDa forms in nonpregnant UVSM to 100 kDa throughout pregnancy, reversal occurring >30 days postpartum. The 39-kDa beta(1)-subunit was the primary regulatory subunit. Levels of 100-kDa alpha-subunit rose approximately 70% during placentation (P < 0.05) and were unchanged in the last two-thirds of pregnancy; in contrast, beta(1)-protein rose throughout pregnancy (R(2) = 0.996; P < 0.001; n = 13), increasing 50% during placentation and approximately twofold in the remainder of gestation. Although UVSM soluble guanylyl cyclase was unchanged, cGMP and protein kinase G(1alpha) increased (P < 0.02), paralleling the rise and fall in beta(1)-protein during pregnancy and the puerperium. BK(Ca) inhibition not only decreased UA nitric oxide (NO)-induced relaxation but also enhanced alpha-agonist-induced vasoconstriction. UVSM BK(Ca) modify relaxation-contraction responses in the last two-thirds of ovine pregnancy, and this is associated with alterations in alpha-subunit composition, alpha:beta(1)-subunit stoichiometry, and upregulation of the cGMP-dependent pathway, suggesting that BK(Ca) activation via NO-cGMP and beta(1) augmentation may contribute to the regulation of UPBF.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19470517      PMCID: PMC2716109          DOI: 10.1152/ajpheart.01185.2008

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  56 in total

Review 1.  Evidence for altered placental blood flow and vascularity in compromised pregnancies.

Authors:  Lawrence P Reynolds; Joel S Caton; Dale A Redmer; Anna T Grazul-Bilska; Kimberly A Vonnahme; Pawel P Borowicz; Justin S Luther; Jacqueline M Wallace; Guoyao Wu; Thomas E Spencer
Journal:  J Physiol       Date:  2006-02-09       Impact factor: 5.182

2.  Vascular development in early ovine gestation: carotid smooth muscle function, phenotype, and biochemical markers.

Authors:  Catalina Hutanu; Blair E Cox; Kevin DeSpain; Xiao-Tie Liu; Charles R Rosenfeld
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-05-02       Impact factor: 3.619

3.  Nitric oxide contributes to estrogen-induced vasodilation of the ovine uterine circulation.

Authors:  C R Rosenfeld; B E Cox; T Roy; R R Magness
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

4.  Uteroplacental production of eicosanoids in ovine pregnancy.

Authors:  R R Magness; M D Mitchell; C R Rosenfeld
Journal:  Prostaglandins       Date:  1990-01

5.  Ca(2+)-activated K(+) channels modulate basal and E(2)beta-induced rises in uterine blood flow in ovine pregnancy.

Authors:  C R Rosenfeld; D N Cornfield; T Roy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-07       Impact factor: 4.733

6.  Placental growth throughout the last two thirds of pregnancy in sheep: vascular development and angiogenic factor expression.

Authors:  Pawel P Borowicz; Daniel R Arnold; Mary Lynn Johnson; Anna T Grazul-Bilska; Dale A Redmer; Lawrence P Reynolds
Journal:  Biol Reprod       Date:  2006-10-18       Impact factor: 4.285

7.  Ovine fetoplacental sulfoconjugation and aromatization of dehydroepiandrosterone.

Authors:  C R Rosenfeld; R J Worley; L Milewich; N F Grant; C R Parker
Journal:  Endocrinology       Date:  1980-06       Impact factor: 4.736

8.  Downregulation of cGMP-dependent protein kinase-1 activity in the corpus cavernosum smooth muscle of diabetic rabbits.

Authors:  Shaohua Chang; Joseph A Hypolite; Marielena Velez; Arun Changolkar; Alan J Wein; Samuel Chacko; Michael E DiSanto
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-06-17       Impact factor: 3.619

9.  Pregnancy increases soluble and particulate guanylate cyclases and decreases the clearance receptor of natriuretic peptides in ovine uterine, but not systemic, arteries.

Authors:  H Itoh; I M Bird; K Nakao; R R Magness
Journal:  Endocrinology       Date:  1998-07       Impact factor: 4.736

10.  Local and systemic estradiol-17 beta: effects on uterine and systemic vasodilation.

Authors:  R R Magness; C R Rosenfeld
Journal:  Am J Physiol       Date:  1989-04
View more
  29 in total

1.  Chronic hypoxia suppresses pregnancy-induced upregulation of large-conductance Ca2+-activated K+ channel activity in uterine arteries.

Authors:  Xiang-Qun Hu; Daliao Xiao; Ronghui Zhu; Xiaohui Huang; Shumei Yang; Sean M Wilson; Lubo Zhang
Journal:  Hypertension       Date:  2012-06-04       Impact factor: 10.190

2.  Large conductance Ca2+-activated K+ channels modulate uterine α1-adrenergic sensitivity in ovine pregnancy.

Authors:  Charles R Rosenfeld; Linda S Hynan; Xiao-tie Liu; Timothy Roy
Journal:  Reprod Sci       Date:  2013-09-11       Impact factor: 3.060

3.  Regulation of the cGMP-cPKG pathway and large-conductance Ca2+-activated K+ channels in uterine arteries during the ovine ovarian cycle.

Authors:  Liaqat H Khan; Charles R Rosenfeld; Xiao-Tie Liu; Ronald R Magness
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-17       Impact factor: 4.310

4.  MicroRNA-210 Targets Ten-Eleven Translocation Methylcytosine Dioxygenase 1 and Suppresses Pregnancy-Mediated Adaptation of Large Conductance Ca2+-Activated K+ Channel Expression and Function in Ovine Uterine Arteries.

Authors:  Xiang-Qun Hu; Chiranjib Dasgupta; Daliao Xiao; Xiaohui Huang; Shumei Yang; Lubo Zhang
Journal:  Hypertension       Date:  2017-07-24       Impact factor: 10.190

5.  Prolonged uterine artery nitric oxide synthase inhibition modestly alters basal uteroplacental vasodilation in the last third of ovine pregnancy.

Authors:  Charles R Rosenfeld; Timothy Roy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-08-15       Impact factor: 4.733

6.  Pregnancy increases myometrial artery myogenic tone via NOS- or COX-independent mechanisms.

Authors:  Delrae M Eckman; Ridhima Gupta; Charles R Rosenfeld; Timothy M Morgan; Shelton M Charles; Heather Mertz; Lorna G Moore
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-06-27       Impact factor: 3.619

7.  Smooth muscle relaxation and activation of the large conductance Ca(++)-activated K+ (BK(Ca)) channel by novel oestrogens.

Authors:  J Maher; A C Hunter; J G Mabley; J Lippiat; M C Allen
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

8.  Direct effect of chronic hypoxia in suppressing large conductance Ca(2+)-activated K(+) channel activity in ovine uterine arteries via increasing oxidative stress.

Authors:  Xiang-Qun Hu; Xiaohui Huang; Daliao Xiao; Lubo Zhang
Journal:  J Physiol       Date:  2015-12-21       Impact factor: 5.182

9.  Chronic hypoxia inhibits pregnancy-induced upregulation of SKCa channel expression and function in uterine arteries.

Authors:  Ronghui Zhu; Xiang-Qun Hu; Daliao Xiao; Shumei Yang; Sean M Wilson; Lawrence D Longo; Lubo Zhang
Journal:  Hypertension       Date:  2013-05-28       Impact factor: 10.190

10.  Large conductance Ca2+-activated and voltage-activated K+ channels contribute to the rise and maintenance of estrogen-induced uterine vasodilation and maintenance of blood pressure.

Authors:  Charles R Rosenfeld; Timothy Roy
Journal:  Endocrinology       Date:  2012-10-15       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.